A personalized and integrative approach to cancer care

Source: www.mdnews.com Author: staff With the recent move to a newly renovated office and infusion center at the corner of Tank Farm Road and Broad Street in San Luis Obispo, Tom Spillane, M.D.; Jim Malone, M.D.; and Deborah Villa, M.D., have renamed the practice Coastal Integrative Cancer Care (CICC), in order to reflect their commitment to a multidisciplinary, collaborative approach to the treatment of cancer. The group, along with Tim Souchek, PA-C, and a dedicated professional oncology-nursing staff, has been the provider of state-of-the-art medical oncology and hematology care in San Luis Obispo County for more than 10 years. However, the new CICC is now able to maximize patients’ treatment outcomes by integrating the latest scientific and technologic information with complementary therapies. Integrative medicine refers to the fusion of complementary therapies (for which there is evidence of safety and effectiveness) with standard Western medical treatments. The term “integrative oncology” has been developed to describe the integration of mainstream cancer care with nonpharmacologic, evidence-based complementary therapies, examples of which include: dietary changes, exercise, physical therapy, naturopathic medicine, chiropractic medicine, acupuncture, massage therapy, aromatherapy, Reiki, Yoga, meditation, guided imagery/hypnotherapy, expressive arts, Tai Chi, Qigong, resistance training, aerobic training programs and dietary interventions. CICC incorporates these interventions through a host of local providers and resource centers, including the Hearst Cancer Resource Center and The Wellness Community. CICC makes every effort to tailor treatments to individual patients based on science and clinical research. The term “personalized medicine” has also been recently coined to describe [...]

El Camino hospital institute launches genetic testing services

Source: sanjose.bizjournals.com Author: staff El Camino Hospital debuts the Genomic Medicine Institute — the first center of its type in the United States — on March 26. Jon Friedenberg, El Camino vice president and head of the Institute, said Silicon Valley is the epicenter of genomic medicine, with many venture capitalists funding and companies developing products in this arena. “It makes sense that we’d be early adopters to this type of personalized medicine,” he said. The institute will start with a $1.2 million budget and a $500 million operating budget. “We’re relying on philanthropy to support us through the first few years,” El Camino Hospital CEO Ken Graham said. “But we think the testing will make up the difference in cost efficiencies in the hospital and in our labs. And as time goes on, I think we’ll be able to demonstrate great success.” The institute’s goal is to provide an infrastructure to support physicians and patients in genetic testing, counseling and genomic-based therapies. Friedenberg said infrastructure is critical because even if a physician is an early adopter of genomic testing, he or she needs a system to provide pre- and post-test counseling specific to each disease. One of the tests the center will offer is Oncotype DX, a test for women with breast cancer, from Genomic Health Inc. in Redwood City. It will enable their physicians to assess whether chemotherapy is the best course for treatment, since 20 percent of breast cancer patients don’t respond to chemotherapy. “If we can [...]

Go to Top